-
Abdul-Fattah AM, Truong-Le V, Yee L, Pan E, Ao Y, Kalonia DS, Pikal MJ, 2007: Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability ò: stability of a vaccine[J]. Pharm Res, 24, 715-727. doi: 10.1007/s11095-006-9191-2
-
Babu GN, Bawari M, 1997: Single microinjection of L-glutamate induces oxidative stress in discrete regions of rat brain[J]. Biochem Mol Biol Int, 43, 1207-1217.
-
Baron MD, Iqbal M, Nair V, 2018: Recent advances in viral vectors in veterinary vaccinology[J]. Curr Opin Virol, 29, 1-7. doi: 10.1016/j.coviro.2018.02.002
-
Basu A, Domb AJ, 2018: Recent advances in polyanhydride based biomaterials[J]. Adv Mater, 30, e1706815-. doi: 10.1002/adma.201706815
-
Borde A, Larsson A, Holmgren J, Nygren E, 2011: Preparation and evaluation of a freeze-dried oral killed cholera vaccine formulation[J]. Eur J Pharm Biopharm, 79, 508-518. doi: 10.1016/j.ejpb.2011.06.009
-
Briggs H, Ilett S, 1993: Weak link in vaccine cold chain[J]. BMJ, 306, 557-558. doi: 10.1136/bmj.306.6877.557
-
Chen C, Han D, Cai C, Tang X, 2010: An overview of liposome lyophilization and its future potential[J]. J Control Release, 142, 299-311. doi: 10.1016/j.jconrel.2009.10.024
-
Chen S, 2012: Investigation on formulation and preparation of adenovirus encoding human endostatin lyophilized powders[J]. Int J Pharm, 427, 145-152. doi: 10.1016/j.ijpharm.2011.12.056
-
Hansen LJJ, Daoussi R, Vervaet C, Remon JP, De Beer TRM, 2015: Freeze-drying of live virus vaccines: a review[J]. Vaccine, 33, 5507-5519. doi: 10.1016/j.vaccine.2015.08.085
-
Jang YH, Seong BL, 2013: Cross-protective immune responses elicited by live attenuated influenza vaccines[J]. Yonsei Med J, 54, 271-282. doi: 10.3349/ymj.2013.54.2.271
-
Kasper JC, Friess W, 2011: The freezing step in lyophilization: physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals[J]. Eur J Pharm Biopharm, 78, 248-263. doi: 10.1016/j.ejpb.2011.03.010
-
Kraan H, van Herpen P, Kersten G, Amorij JP, 2014: Development of thermostable lyophilized inactivated polio vaccine[J]. Pharm Res, 31, 2618-2629. doi: 10.1007/s11095-014-1359-6
-
Lapuente D, Ruzsics Z, Thirion C, Tenbusch M, 2018: Evaluation of adenovirus 19a as a novel vector for mucosal vaccination against influenza A viruses[J]. Vaccine, 36, 2712-2720. doi: 10.1016/j.vaccine.2018.02.075
-
Madan M, Sikriwal D, Sharma G, Shukla N, Mandyal AK, Kale S, Gill D, 2018: Rational design of heat stable lyophilized rotavirus vaccine formulations[J]. Hum Vaccin Immunother, 14, 2132-2141. doi: 10.1080/21645515.2018.1487499
-
Melief CJ, van Hall T, Arens R, Ossendorp F, van der Burg SH, 2015: Therapeutic cancer vaccines[J]. J Clin Investig, 125, 3401-3412. doi: 10.1172/JCI80009
-
Meri S, Jordens M, Jarva H, 2008: Microbial complement inhibitors as vaccines[J]. Vaccine, 26, I113-I117.
-
Mody KT, Mahony D, Cavallaro AS, Stahr F, Qiao SZ, Mahony TJ, Mitter N, 2014: Freeze-drying of ovalbumin loaded mesoporous silica nanoparticle vaccine formulation increases antigen stability under ambient conditions[J]. Int J Pharm, 465, 325-332. doi: 10.1016/j.ijpharm.2014.01.037
-
Ohtake S, Martin RA, Saxena A, Lechuga Ballesteros D, Santiago AE, Barry EM, Le Truong V, 2011: Formulation and stabilization of francisella tularensis live vaccine strain[J]. J Pharm Sci-US, 100, 3076-3087. doi: 10.1002/jps.22563
-
Orr MT, 2014: Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization[J]. J Control Release, 177, 20-26. doi: 10.1016/j.jconrel.2013.12.025
-
Peetermans J, 1996: Factors affecting the stability of viral vaccines[J]. Dev Biol Stand, 87, 97-101.
-
Prabhu M, Bhanuprakash V, Venkatesan G, Yogisharadhya R, Bora DP, Balamurugan V, 2014: Evaluation of stability of live attenuated camelpox vaccine stabilized with different stabilizers and reconstituted with various diluents[J]. Biologicals, 42, 169-175. doi: 10.1016/j.biologicals.2014.02.001
-
Qiu S et al (2014) Fusion-expressed CTB improves both systemic and mucosal T-cell responses elicited by an intranasal DNA priming/intramuscular recombinant vaccinia boosting regimen J. Immunol Res 2014: 308732
-
Reid MC, 2019: Models to predict the public health impact of vaccine resistance: a systematic review[J]. Vaccine, 37, 4886-4895. doi: 10.1016/j.vaccine.2019.07.013
-
Shin WJ, Hara D, Gbormittah F, Chang H, Chang BS, Jung JU (2018) Development of thermostable lyophilized sabin inactivated poliovirus vaccine. Mbio 9: e02287-18
-
Shokri S, Shahkarami MK, Shafyi A, Mohammadi A, Esna-Ashari F, Hamta A, 2019: Evaluation of the thermal stability of live-attenuated Rubella vaccine (Takahashi strain) formulated and lyophilized in different stabilizers[J]. J Virol Methods, 264, 18-22. doi: 10.1016/j.jviromet.2018.08.013
-
Siow CR, Wan SHP, Chan LW, 2016: Application of freeze-drying in the development of oral drug delivery systems[J]. Expert Opin Drug Deliv, 13, 1595-1608. doi: 10.1080/17425247.2016.1198767
-
Stewart M, Ward SJ, Drew J, 2014: Use of adenovirus as a model system to illustrate a simple method using standard equipment and inexpensive excipients to remove live virus dependence on the cold-chain[J]. Vaccine, 32, 2931-2938. doi: 10.1016/j.vaccine.2014.02.033
-
Walters RH, Bhatnagar B, Tchessalov S, Izutsu KI, Tsumoto K, Ohtake S, 2014: Next generation drying technologies for pharmaceutical applications[J]. J Pharm Sci, 103, 2673-2695. doi: 10.1002/jps.23998
-
Yusuf H, Nugraheni RW, Setyawan D, 2019: Effect of cellulose derivative matrix and oligosaccharide on the solid state and physical characteristics of dimethyldioctadecylammoniumliposomes for vaccine[J]. Res Pharm Sci, 14, 1-11. doi: 10.4103/1735-5362.251847
-
Zheng Y, Lee PW, Wang C, Thomas LD, Stewart PL, Steinmetz NF, Pokorski JK (2019) Freeze-drying to produce efficacious CPMV virus-like particles. Nano Lett 19: 2099–2105